S Bioprocessing Technology Institute provides entered into an contract with one of the world&39 rx pharmacy.

A*Celebrity, Roche partner to recognize novel medication targets for cancer treatment Partnership with Roche Pharma Study and Early Development leverages a unique discovery by A*Celebrity's Bioprocessing Technology Institute to build up new approaches for cancer detection and treatment A*STAR's Bioprocessing Technology Institute provides entered into an contract with one of the world's largest pharmaceutical company, Roche, to recognize novel drug candidates for the procedure and detection of cancer rx pharmacy . The partnership brings together BTI's features in novel antibody discovery and Roche's knowledge in developing monoclonal antibody therapeutics, checking the chance of improved treatment for cancers, a leading reason behind death worldwide.

Proton therapy is certainly well-tolerated in prostate cancer individuals. Where: McCormick Place West, Room 176b/c or on the internet at News briefing 4 When: Tuesday, November 3, at 12:00 p.m. ; 1:00 p.m. What: Information briefing with live webcast from ASTRO’s 51st Annual Meeting. Study findings previewed: Shorter radiation training course stops cancer growth in high-risk prostate tumor patients. Shorter radiation training course as effective as standard therapy for prostate tumor recurrence. Where: McCormick Place West, Area 176b/c, or on the Web at How: To participate in the webcasts, click on the links above to see slides and listen to the audio of the conference live on the internet..